IL47225A0 - Synergistic pharmaceutical compositions comprising an ergot clavine alkaloid and a phosphodiesterase inhibitor - Google Patents

Synergistic pharmaceutical compositions comprising an ergot clavine alkaloid and a phosphodiesterase inhibitor

Info

Publication number
IL47225A0
IL47225A0 IL47225A IL4722575A IL47225A0 IL 47225 A0 IL47225 A0 IL 47225A0 IL 47225 A IL47225 A IL 47225A IL 4722575 A IL4722575 A IL 4722575A IL 47225 A0 IL47225 A0 IL 47225A0
Authority
IL
Israel
Prior art keywords
clavine
ergot
alkaloid
pharmaceutical compositions
phosphodiesterase inhibitor
Prior art date
Application number
IL47225A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL47225A0 publication Critical patent/IL47225A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL47225A 1974-05-06 1975-05-05 Synergistic pharmaceutical compositions comprising an ergot clavine alkaloid and a phosphodiesterase inhibitor IL47225A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH611774 1974-05-06
CH611874 1974-05-06

Publications (1)

Publication Number Publication Date
IL47225A0 true IL47225A0 (en) 1975-11-25

Family

ID=25699001

Family Applications (1)

Application Number Title Priority Date Filing Date
IL47225A IL47225A0 (en) 1974-05-06 1975-05-05 Synergistic pharmaceutical compositions comprising an ergot clavine alkaloid and a phosphodiesterase inhibitor

Country Status (4)

Country Link
DE (1) DE2518677A1 (xx)
FR (1) FR2269948A1 (xx)
IL (1) IL47225A0 (xx)
NL (1) NL7505202A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2856393C2 (de) * 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
DE2935515A1 (de) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Arzneipraeparat
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden

Also Published As

Publication number Publication date
NL7505202A (nl) 1975-11-10
FR2269948A1 (en) 1975-12-05
DE2518677A1 (de) 1975-11-20

Similar Documents

Publication Publication Date Title
NZ189253A (en) Amine derivatives and pharmaceutical compositions
NZ182011A (en) N- -haolethyl (or hydroxyethyl)-nortropine benzilates salts and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ182837A (en) Glucosamine derivatives and pharmaceutical compositions
NZ181010A (en) Heteroaryl compounds and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ185105A (en) Thiazolidine derivatives and pharmaceutical compositions
NZ182665A (en) Amine derivatives and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
NZ186692A (en) Morphine derivatives and pharmaceutical compositions
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ181959A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ182190A (en) Clavulanic acid derivatives and pharmaceutical compositions
NZ181009A (en) Heteroaryl derivatives and pharmaceutical compositions
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ186693A (en) Morphine derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions